-
-
-
-
-
-
-
BridgeBio Pharma Inc. (BBIO) Announces Pricing of Public Offering of Common Stock
-
-
-
-
-
-
-
BridgeBio Pharma (BBIO) Reports Positive Long-Term Data from an Ongoing Phase 2 Study
-
-
-
-
-
-
-
BridgeBio Pharma Inc. (BBIO) Announces Proposed $150M Offering
-
-
-
-
-
-
-
BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock
-
-
-
-
-
-
-
Form 4 BridgeBio Pharma, Inc. For: May 05 Filed by: Kumar Neil
-
-
72,923 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

